Argentina joins international pneumococcal vaccine effectiveness study in children

Argentina's Malbrán Institute will participate in a multi-country study assessing pneumococcal vaccine effectiveness in children under 5, alongside centers in the US, Israel, and Europe, running until 2028. The study's scope and expected impact are not yet detailed. This adds Latin American data to global vaccine efficacy evidence, potentially informing regional immunization policy.